biosimilars
Pfizer Builds Global Biotechnology Center In China
The Center will produce high-quality, affordable biosimilar medicines for patients in China and around the world.
Dollars And Drugs
SMU Professor Locknie Hsu studies how trade deals affect the public’s access to affordable medicines and healthcare.
India’s First Lady Of Biotech
Ms. Kiran Mazumdar-Shaw, chairman and managing director of Biocon Limited, talks to Asian Scientist Magazine about the challenges faced by biotech companies in Asia.
Celltrion Files For FDA Approval For Biosimilar Drug
Celltrion predicts that it is one year away from approval for Remsima®, a biosimilar based on an originator drug from Janssen Biotech.
